This study is testing two different group therapy programs for people with Opioid Use Disorder (OUD) who are also taking medication for OUD (MOUD), such as methadone, naloxone, naltrexone, or buprenorphine. You could be assigned to either the Minds and Mentors program, which includes mindfulness-based therapy and peer support, or a Twelve Step Intervention Group. Researchers want to see if the Minds and Mentors program helps people stick with their MOUD treatment, reduces relapse and cravings, and improves anxiety, stress, and depression. The study aims to enroll 240 participants and is looking for adults aged 19 and older who have been diagnosed with OUD recently and are currently in the maintenance phase of MOUD. The current recruitment status is unclear.

Study design

This is an interventional study where 240 participants will be randomly assigned to one of two group therapy programs: Minds and Mentors or the Twelve Step Intervention Group.

What's involved

You would attend weekly group therapy sessions for 12 weeks. The Minds and Mentors program includes 8 weeks led by a licensed counselor and 4 additional sessions led by a certified recovery support specialist.

Compensation

Not stated in the trial record.

Follow-up

Your adherence rate to MOUD will be measured at 9 months after starting the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.